Guy Heynen
Director/Board Member presso ACTICOR BIOTECH SAS
Profilo
Guy Heynen is currently the Chief Executive Officer at Dr. Heynen Consulting, Director at Acticor Biotech SAS, Director at AbolerIS Pharma, Director at NeuVasQ Biotechnologies SA, and Director at Adipopharma SAS.
He previously worked as a Non-Executive Director at Ogeda SA, Medical Director at Pfizer AG, Director-Medical Affairs at Anbics AG, Director at Pluriomics BV, Director at Dim3 SA, Director at Ncardia SA, Director at ChromaCure SA, Medical Team Leader at Pfizer Inc., President at ProGenosis SA, Chief Medical, Clinical & Regulatory Officer at Bone Therapeutics SA, and President at Creativenture SA. He also worked as a Principal at Centre Hospitalier Universitaire de Liege.
Dr. Heynen holds a doctorate degree from Centre Hospitalier Universitaire de Liege.
Posizioni attive di Guy Heynen
| Società | Posizione | Inizio |
|---|---|---|
| ACTICOR BIOTECH SAS | Director/Board Member | - |
Adipopharma
 Adipopharma Miscellaneous Commercial ServicesCommercial Services Adipopharma is a French biotech company that focuses on developing treatments for insulin resistance, type 2 diabetes, and related conditions. | Director/Board Member | - |
AbolerIS Pharma
 AbolerIS Pharma Pharmaceuticals: MajorHealth Technology AbolerIS Pharma develops therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune, and degenerative diseases. The company was founded by Carole Guillonneau, Ignacio Anegon and François-Xavier Hubert and is headquartered in Nantes, France. | Director/Board Member | - |
| Guy Heynen Consulting | Chief Executive Officer | - |
NeuVasQ Biotechnologies SA
 NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke. | Director/Board Member | - |
Precedenti posizioni note di Guy Heynen
| Società | Posizione | Fine |
|---|---|---|
| Anbics AG | Chief Tech/Sci/R&D Officer | 01/01/2006 |
| Pfizer AG | Chief Tech/Sci/R&D Officer | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Pluriomics BV
 Pluriomics BV BiotechnologyHealth Technology Pluriomics BV provides cardiac drug discovery and safety assessment solutions. The company was founded by Stefan Braam, Christine Mummery, Robert Passier and Herman Spolders in 2010 and is headquartered in Leiden, the Netherlands. | Director/Board Member | - |
| ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Guy Heynen
| Centre Hospitalier Universitaire de Liege | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACTICOR BIOTECH SAS | Health Technology |
| Aziende private | 14 |
|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Health Technology |
ProGenosis SA
 ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Health Technology |
| Pfizer AG | |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
Creativenture SA
 Creativenture SA Food DistributorsDistribution Services Creativenture SA produces and markets wines. It provides its products through Custom Wines, Gusto World and Courage Trading. The company is headquartered in Alleur, Belgium | Distribution Services |
| Anbics AG | |
Pluriomics BV
Pluriomics BV BiotechnologyHealth Technology Pluriomics BV provides cardiac drug discovery and safety assessment solutions. The company was founded by Stefan Braam, Christine Mummery, Robert Passier and Herman Spolders in 2010 and is headquartered in Leiden, the Netherlands. | Health Technology |
| Guy Heynen Consulting | |
DIM3 SA
 DIM3 SA Packaged SoftwareTechnology Services DIM3 SA develops decision support application software and medical devices. The firm offers Scorso, an app for the screening and follow-up of disease-related malnutrition; Nutrow, a decision support software for an optimization of clinical nutrition; and Biocorder, a connected clinical mobile assistant. The company was founded by Jean Claude Havaux on September 23, 2004 and is headquartered in Liege, Belgium. | Technology Services |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Commercial Services |
ChromaCure SA
 ChromaCure SA Pharmaceuticals: MajorHealth Technology ChromaCure SA develops therapeutic molecules to fight against cancer. The company is based in Charleroi, Belgium. The Belgian company was founded in 2018 by Cedric Blanpain, who has been the CEO since 2018. | Health Technology |
AbolerIS Pharma
AbolerIS Pharma Pharmaceuticals: MajorHealth Technology AbolerIS Pharma develops therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune, and degenerative diseases. The company was founded by Carole Guillonneau, Ignacio Anegon and François-Xavier Hubert and is headquartered in Nantes, France. | Health Technology |
NeuVasQ Biotechnologies SA
NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke. | Health Technology |
Adipopharma
Adipopharma Miscellaneous Commercial ServicesCommercial Services Adipopharma is a French biotech company that focuses on developing treatments for insulin resistance, type 2 diabetes, and related conditions. | Commercial Services |
- Borsa valori
- Insiders
- Guy Heynen
